ETFs

Stifel Nicolaus Cuts Onto Innovation (NYSE:ONTO) Price ...

Onto Innovation (NYSE:ONTO – Free Report) had its target price reduced by Stifel...

Stifel Nicolaus Issues Pessimistic Forecast for Skecher...

Skechers U.S.A. (NYSE:SKX – Free Report) had its target price cut by Stifel Nico...

MarketAxess (NASDAQ:MKTX) Price Target Cut to $225.00 b...

MarketAxess (NASDAQ:MKTX – Free Report) had its target price decreased by Barcla...

Raymond James Cuts Skechers U.S.A. (NYSE:SKX) Price Tar...

Skechers U.S.A. (NYSE:SKX – Free Report) had its price target cut by Raymond Jam...

Microchip Technology (NASDAQ:MCHP) Given New $60.00 Pri...

Microchip Technology (NASDAQ:MCHP – Free Report) had its price target cut by Key...

Zimmer Biomet’s (ZBH) “Market Outperform” Rating Reaffi...

JMP Securities restated their market outperform rating on shares of Zimmer Biome...

Lumentum’s (LITE) Buy Rating Reiterated at Rosenblatt S...

Rosenblatt Securities restated their buy rating on shares of Lumentum (NASDAQ:LI...

Desert Gold Ventures (CVE:DAU) Stock Price Up 25% – Ti...

Shares of Desert Gold Ventures Inc. (CVE:DAU – Get Free Report) shot up 25% duri...

Desert Gold Ventures (CVE:DAU) Stock Price Up 25% – St...

Desert Gold Ventures Inc. (CVE:DAU – Get Free Report) shares traded up 25% on Sa...

BorgWarner (NYSE:BWA) Price Target Raised to $41.00 at ...

BorgWarner (NYSE:BWA – Free Report) had its price target raised by Wells Fargo &...

Camden Property Trust (NYSE:CPT) Price Target Raised to...

Camden Property Trust (NYSE:CPT – Free Report) had its target price upped by Sti...

Brokerages Set International Flavors & Fragrances Inc. ...

Shares of International Flavors & Fragrances Inc. (NYSE:IFF – Get Free Report) h...

Magnera (MAGN) versus The Competition Financial Review

Magnera (NYSE:MAGN – Get Free Report) is one of 18 public companies in the “Pape...

JPMorgan Chase & Co. Raises Insmed (NASDAQ:INSM) Price ...

Insmed (NASDAQ:INSM – Free Report) had its price objective lifted by JPMorgan Ch...

SCHG: Sell Strength

Needham & Company LLC Reaffirms “Hold” Rating for Neuro...

Needham & Company LLC reiterated their hold rating on shares of Neurocrine Biosc...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.